🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3470
-0.0198 (-5.40%)
At close: Nov 19, 2026, 4:00 PM EST
0.3600
+0.0130 (3.75%)
After-hours: Nov 19, 2026, 6:41 PM EST

Neumora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
653041,7132,604--
Market Cap Growth
-84.87%-82.24%-34.22%---
Enterprise Value
331531,3742,090--
Last Close Price
0.371.7910.6017.05--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.732.935.975.55--
P/TBV Ratio
3.562.935.975.55--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.890.530.010.010.020.01
Net Debt / Equity Ratio
-1.73-1.23-1.06-0.98-0.97-1.01
Net Debt / EBITDA Ratio
0.170.541.162.453.175.10
Net Debt / FCF Ratio
0.190.621.662.733.015.34
Quick Ratio
3.695.6310.2918.0815.7317.59
Current Ratio
4.095.8710.5119.0516.3717.85
Return on Equity (ROE)
-252.71%-121.21%-64.48%-54.49%-32.67%-80.18%
Return on Assets (ROA)
-139.57%-93.27%-59.96%-51.15%-30.60%-75.67%
Return on Capital Employed (ROCE)
-260.20%-148.90%-91.80%-39.90%-30.50%-19.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-304.23%-77.89%-14.24%-9.06%--
FCF Yield
-253.33%-67.87%-10.73%-6.45%--
Buyback Yield / Dilution
-11.70%-2.52%-145.12%-138.99%-24.25%-68.46%
SEC Filings: 10-K · 10-Q